Wu, X., Wanders, A., Wardega, P., Tinge, B., Gedda, L., Bergstrom, S., . . . Ekman, S. (2009). Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin. Nature Publishing Group.
استشهاد بنمط شيكاغوWu, X., et al. Hsp90 Is Expressed and Represents a Therapeutic Target in Human Oesophageal Cancer Using the Inhibitor 17-allylamino-17-demethoxygeldanamycin. Nature Publishing Group, 2009.
MLA استشهادWu, X., et al. Hsp90 Is Expressed and Represents a Therapeutic Target in Human Oesophageal Cancer Using the Inhibitor 17-allylamino-17-demethoxygeldanamycin. Nature Publishing Group, 2009.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.